Have a personal or library account? Click to login
Prolactinoma - which patients react favorably to cabergoline medication? Cover

Prolactinoma - which patients react favorably to cabergoline medication?

Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
By: Savas Karatas,  Yalcin Hacioglu and  Taskin Rakicioglu  
Open Access
|Oct 2022

Metrics

DOI: https://doi.org/10.2478/enr-2022-0030 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 279 - 283
Published on: Oct 20, 2022
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
prolactinoma,
pituitary,
endocrinology
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2022 Savas Karatas, Yalcin Hacioglu, Taskin Rakicioglu, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 4 (October 2022)Next article